Septerna, Inc.

Ownership Transactions Reported by 18 Insiders

Symbol
SEPN on Nasdaq
Industry
Pharmaceutical Preparations
Location
250 East Grand Avenue, Suite 65, South San Francisco, CA

Insiders trading volume in the past year

Septerna, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Third Rock Ventures VI, L.P. 10%+ Owner $62.6M +$6.28M +11.2% Feb 24, 2025
Third Rock Ventures V, L.P. 10%+ Owner $54.8M Oct 28, 2024
Ra Capital Management, L.P. Director, 10%+ Owner $8.61M Jun 17, 2025
Jeffrey Finer Chief Executive Officer, Director $2.28M +$97K +4.44% Aug 7, 2025
Daniel D. Long SVP, Drug Discovery $1.68M -$63.2K -3.63% Nov 10, 2025
Uwe Klein SVP, Biological Sciences $1.44M Aug 18, 2025
Elizabeth Bhatt President and COO $1.02M Aug 7, 2025
Alan Ezekowitz Director $813K +$608K +296% Jun 17, 2025
Ran Xiao Interim CFO $340K Oct 24, 2024
Gil M. Labrucherie Chief Financial Officer $234K +$229K +4739% Aug 7, 2025
Bernard Coulie Director Jun 17, 2025
Keith Michael Gottesdiener Director Sep 25, 2025
Shalini Sharp Director Jun 17, 2025
Abraham Bassan Director Jun 17, 2025
Jake Simson Director Jun 17, 2025
Samira Shaikhly Chief People Officer Aug 7, 2025
Jeffrey K. Tong Director Jun 17, 2025
Jae B. Kim Chief Medical Officer Aug 7, 2025

Recent Insider Transactions by Companies or Individuals for Septerna, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.